6-methyl-3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopentapyrazole | 1050199-71-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 6-methyl-3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopentapyrazole
• 英文别名: 6-methyl-3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
• CAS: 1050199-71-7
• 化学式: C₈H₁₀N₆
• 分子量: 190.208
• InChiKey: IDGNMJJLWFSPRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  83.1
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  6-Methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carbonitrile 在 sodium azide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 6-methyl-3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopentapyrazole
  参考文献：
  名称：

  3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

  摘要：

  The discovery and profiling of 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopeiitapyrazole (5a, MK-0354), a partial agonist of GPR 109a, is described. Compound 5a retained the plasma free fatty acid lowering effects in mice associated with GPR109a agonism, but did not induce vasodilation at the maximum feasible dose. Moreover, preadministration of 5a blocked the flushing effect induced by nicotinic acid but not that induced by PGD(2). This profile made 5a a suitable candidate for further study for the treatment of dyslipidemia.

  DOI：

  10.1021/jm800258p